Nutritional Intervention With Tenebrio Molitor Powder in Children With Chronic Malnutrition in the Democratic Republic of the Congo (SANTE)

SANTE INITIATIVE: Nutritional Intervention With Tenebrio Molitor Powder in Children With Chronic Malnutrition in the Democratic Republic of the Congo

The goal of this clinical trial is to evaluate whether a dietary supplement based on Tenebrio molitor (mealworm flour) can improve nutritional status and biomarkers of micronutrient deficiency in children aged 2-10 years.

The main questions it aims to answer are:

• Does regular supplementation with Tenebrio molitor flour improve chronic malnutrition status

Researchers will compare the intervention group (children receiving Tenebrio molitor flour supplement) with the control group (children receiving a traditional maize-soy flour supplement) to assess differences in biochemical and anthropometric outcomes after the intervention period.

Participants will:

  • Participate in baseline and follow-up anthropometric and blood sample assessments (hemoglobin, albumin, zinc, iron, calcium, magnesium, vitamin A, folic acid, vitamin B12, prealbumin).
  • Consume a daily dietary supplement (either Tenebrio molitor flour or maize-soy flour) for the duration of the intervention.
  • Provide information on dietary intake and general health status through structured questionnaires administered by the research team.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children diagnosed with chronic malnutrition (weight-for-height or BMI below -2 SD according to WHO standards).

Children whose families agree to participate in the intervention and sign the informed consent form.

Exclusion Criteria:

  • Children with severe acute illnesses that may interfere with the intervention.
  • Children with known allergies to the ingredients of the nutritional products provided.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants will receive a daily supplement made from Tenebrio molitor (mealworm) flour for 24 weeks.

The intervention consists of a daily dietary supplement made from Tenebrio molito powder, a sustainable and high-protein insect. Each participant in the intervention group will receive a pre-measured daily dose of Tenebrio molitor The supplement is designed to improve protein quality and micronutrient intake, particularly iron, zinc, and vitamin B12, in children aged 2-10 years.

This intervention differs from traditional nutritional supplements by using Tenebrio molitor as a novel source of animal protein and micronutrients, contributing to sustainable food systems and child nutrition in low-resource settings.

Active Comparator: Control Group
Participants will receive a daily supplement made from maize and soy flour for 24 weeks.

The control supplement is a daily dietary mixture made from maize and soy flour, formulated to match the dose of the intervention supplement but without Tenebrio molitor protein. This preparation represents a conventional plant-based dietary supplement commonly used in nutritional support programs.

It serves as an active comparator to assess the added nutritional and functional benefits of Tenebrio molitor flour in improving biochemical and anthropometric indicators of child nutrition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prealbumin
Time Frame: Baseline (Week 0) and 24 weeks of supplementation.
Prealbumin levels will be measured to assess improvement in protein nutritional status among participants receiving Tenebrio molitor flour supplement compared with those receiving maize-soy flour supplement.
Baseline (Week 0) and 24 weeks of supplementation.
Height-for-Age z-scores (WHO Child Growth Standards)
Time Frame: Baseline, 12 weeks and 24 weeks
To evaluate the effect of Tenebrio molitor supplementation on growth parameters in children. Scale range: z-scores less than or equal to -2 indicate stunting; less than or equal to -3 indicate severe stunting. Values close to 0 reflect adequate growth. High positive values (>+2 or >+3) indicate heights that are significantly above the average
Baseline, 12 weeks and 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Serum Iron Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum iron levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Zinc Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Zinc levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Vitamin B12 Concentration (pg/mL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Vitamin B12 levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Vitamin B9 (Folate) Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Vitamin B9 (Folate) levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Vitamin A Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Vitamin A levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Calcium Concentration (mg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Calcium levels compared to maize-soy flour.
From Baseline to 24 Weeks
Change in Serum Magnesium Concentration (mg/dL)
Time Frame: From Baseline to 24 Weeks
To determine whether Tenebrio molitor flour improves serum Magnesium levels compared to maize-soy flour.
From Baseline to 24 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nerea Martín Calvo, University of Navarra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

December 15, 2025

First Posted (Actual)

December 16, 2025

Study Record Updates

Last Update Posted (Actual)

December 16, 2025

Last Update Submitted That Met QC Criteria

December 15, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stunting of Growth

Clinical Trials on Tenebrio Molitor powder

Subscribe